Skip to main navigation
Skip to search
Skip to main content
Discovery - the University of Dundee Research Portal Home
Search content at Discovery - the University of Dundee Research Portal
Home
Profiles
Research units
Research Outputs
Projects
Datasets
Theses
Activity
Press/Media
Research Facilities
Prizes
Chemotherapy-induced peripheral neuropathy: where are we now?
Lesley A. Colvin
(Lead / Corresponding author)
Population Health and Genomics
Research output
:
Contribution to journal
›
Article
›
peer-review
263
Link opens in a new tab
Citations (Scopus)
287
Downloads (Pure)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Chemotherapy-induced peripheral neuropathy: where are we now?'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Chemotherapy-induced Peripheral Neuropathy
100%
Chemotherapy
20%
Cancer Treatment
10%
Cancer-specific Survival
10%
Instrument Validation
10%
Vulnerability
10%
Metformin
10%
Histone Deacetylase 6 (HDAC6)
10%
Neuropathic Pain
10%
Clinical Efficacy
10%
Preventive Treatment
10%
Alternative Therapeutics
10%
Patient's Will
10%
EORTC
10%
Ion Channels
10%
Clinical Syndromes
10%
Significant Risk Factors
10%
Dose Reduction
10%
Targeted Treatment
10%
Accurate Assessment
10%
Mitochondrial Dysfunction
10%
Therapeutic Avenues
10%
Early Phase Clinical Trials
10%
Amitriptyline
10%
Sodium-to-potassium Ratio
10%
Novel Agents
10%
TRP Channels
10%
Duloxetine
10%
Precision Medicine
10%
Oncological Treatment
10%
Cancer Cure
10%
Novel Analgesics
10%
Gabapentinoids
10%
Neurotoxic Chemotherapy
10%
American Society of Clinical Oncology
10%
Drug Repurposing
10%
Calcium Transient
10%
Immune Cell Interactions
10%
Medicine and Dentistry
Chemotherapy-Induced Peripheral Neuropathy
100%
Cancer Therapy
30%
Clinical Trial
10%
Prevalence
10%
Glycon
10%
Isotopes of Calcium
10%
Ion Channel
10%
Clinical Syndrome
10%
Drug Dose Reduction
10%
Targeted Therapy
10%
Personalized Medicine
10%
Cell Interaction
10%
Clinical Oncology
10%
Neuropathic Pain
10%
Immunocompetent Cell
10%
Drug Withdrawal
10%
Cancer Survival
10%
Amitriptyline
10%
Duloxetine
10%
Drug Repositioning
10%
Gabapentinoid
10%
Transient Receptor Potential Channel
10%
Histone Deacetylase 6
10%
Mitochondrial Disorder
10%
Pharmacology, Toxicology and Pharmaceutical Science
Chemotherapy-Induced Peripheral Neuropathy
100%
Chemotherapy
30%
Malignant Neoplasm
20%
Clinical Trial
10%
Metformin
10%
Isotopes of Potassium
10%
Prevalence
10%
Ion Channel
10%
Analgesic Agent
10%
Syndrome
10%
Amitriptyline
10%
Neuropathic Pain
10%
Transient Receptor Potential Channel
10%
Histone Deacetylase 6
10%
Duloxetine
10%
Drug Repositioning
10%
Gabapentinoid
10%
Neuroscience
Neuropathy
100%
Metformin
10%
Ion Channel
10%
Cell Interaction
10%
Neuropathic Pain
10%
Amitriptyline
10%
Transient Receptor Potential Channel
10%
Histone Deacetylase 6
10%
Duloxetine
10%